FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mikko Hakola

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Disorders

Anatomy

Joints

Co-author Network

Publications

TOP 3
Heidi Mäkinen; Hannu Kautiainen; Pekka Hannonen; Timo Möttönen; Marjatta Leirisalo-Repo; Leena Laasonen; Markku Korpela; Harri Blåfield; Mikko Hakola; Tuulikki Sokka
Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
A Kuuliala; Marjatta Leirisalo-Repo; Timo Möttönen; Pekka Hannonen; Martti Nissilä; Hannu Kautiainen; Markku Korpela; Heikki Julkunen; Mikko Hakola; Heikki Repo
Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Timo Yli-Kerttula; Reijo Luukkainen; U Yli-Kerttula; Timo Möttönen; Mikko Hakola; Markku Korpela; MT Sanila; Jaakko Uksila; Auli Toivanen
Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mikko Hakola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Heidi Mäkinen; Hannu Kautiainen; Pekka Hannonen; Timo Möttönen; Marjatta Leirisalo-Repo; Leena Laasonen; Markku Korpela; Harri Blåfield; Mikko Hakola; Tuulikki Sokka
Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
The Journal of rheumatology 2007;34(2):316-21.
2005: A Kuuliala; Marjatta Leirisalo-Repo; Timo Möttönen; Pekka Hannonen; Martti Nissilä; Hannu Kautiainen; Markku Korpela; Heikki Julkunen; Mikko Hakola; Heikki Repo
Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Clinical and experimental rheumatology 2005;23(2):243-6.
2003: Timo Yli-Kerttula; Reijo Luukkainen; U Yli-Kerttula; Timo Möttönen; Mikko Hakola; Markku Korpela; MT Sanila; Jaakko Uksila; Auli Toivanen
Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.
Annals of the rheumatic diseases 2003;62(9):880-4.
2000: Timo Yli-Kerttula; Reijo Luukkainen; U Yli-Kerttula; Timo Möttönen; Mikko Hakola; Markku Korpela; MT Sanila; J Parviainen; Jaakko Uksila; Raija Vainionpää; Auli Toivanen
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.
Annals of the rheumatic diseases 2000;59(7):565-70.
1999: Timo Möttönen; Pekka Hannonen; Marjatta Leirisalo-Repo; Martti Nissilä; Hannu Kautiainen; Markku Korpela; Leena Laasonen; Heikki Julkunen; Reijo Luukkainen; Kaisa Vuori; Leena Paimela; Harri Blåfield; Markku Hakala; K Ilva; U Yli-Kerttula; Kari Puolakka; Pentti Järvinen; Mikko Hakola; H Piirainen; J Ahonen; I Pälvimäki; Sinikka Forsberg; K Koota; Claes Friman
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Lancet 1999;353(9164):1568-73.